Net Income (Loss) Attributable to Parent in USD of REGENERX BIOPHARMACEUTICALS INC from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
REGENERX BIOPHARMACEUTICALS INC quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q1 2023.
  • REGENERX BIOPHARMACEUTICALS INC Net Income (Loss) Attributable to Parent for the quarter ending 31 Mar 2023 was -$385K, a 9.17% increase year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC Net Income (Loss) Attributable to Parent for the twelve months ending 31 Mar 2023 was -$1.69M, a 2.83% decline year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC annual Net Income (Loss) Attributable to Parent for 2022 was -$1.73M, a 8.12% decline from 2021.
  • REGENERX BIOPHARMACEUTICALS INC annual Net Income (Loss) Attributable to Parent for 2021 was -$1.6M, a 4.88% decline from 2020.
  • REGENERX BIOPHARMACEUTICALS INC annual Net Income (Loss) Attributable to Parent for 2020 was -$1.52M, a 8.48% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

REGENERX BIOPHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$1.69M -$385K +$38.9K +9.17% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 -$1.73M -$391K +$58.7K +13.1% 01 Oct 2022 31 Dec 2022 10-K 11 Apr 2023
Q3 2022 -$1.79M -$367K +$63.3K +14.7% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 -$1.85M -$546K -$207K -61.2% 01 Apr 2022 30 Jun 2022 10-Q 14 Nov 2022
Q1 2022 -$1.64M -$424K -$44.4K -11.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$1.6M -$450K -$81.7K -22.2% 01 Oct 2021 31 Dec 2021 10-K 11 Apr 2023
Q3 2021 -$1.52M -$430K -$97.2K -29.2% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$1.42M -$339K +$97.5K +22.4% 01 Apr 2021 30 Jun 2021 10-Q 14 Nov 2022
Q1 2021 -$1.52M -$380K +$7.04K +1.82% 01 Jan 2021 31 Mar 2021 10-Q 14 Nov 2022
Q4 2020 -$1.52M -$368K -$18.4K -5.28% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 -$1.5M -$333K +$1.31K +0.39% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$1.51M -$436K -$47.7K -12.3% 01 Apr 2020 30 Jun 2020 10-Q 15 Nov 2021
Q1 2020 -$1.46M -$387K -$54.3K -16.3% 01 Jan 2020 31 Mar 2020 10-Q 15 Nov 2021
Q4 2019 -$1.4M -$349K -$85.6K -32.5% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 -$1.32M -$334K +$42.1K +11.2% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$1.36M -$388K -$20.6K -5.59% 01 Apr 2019 30 Jun 2019 10-Q 13 Nov 2020
Q1 2019 -$1.34M -$332K +$653K +66.3% 01 Jan 2019 31 Mar 2019 10-Q 13 Nov 2020
Q4 2018 -$1.99M -$264K -$1.68M -119% 01 Oct 2018 31 Dec 2018 10-K 20 Mar 2020
Q3 2018 -$312K -$376K +$983K +72.3% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$1.29M -$368K -$486K -411% 01 Apr 2018 30 Jun 2018 10-Q 14 Nov 2019
Q1 2018 -$809K -$986K -$1.1M -1002% 01 Jan 2018 31 Mar 2018 10-Q 14 Nov 2019
Q4 2017 $286K $1.42M +$995K +236% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$709K -$1.36M -$2.22M -258% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $1.51M $118K -$2.21M -94.9% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $3.72M $109K +$3.49M 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 $229K $422K +$1.08M 01 Oct 2016 31 Dec 2016 10-K 29 Mar 2018
Q3 2016 -$853K $862K +$1.99M 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$2.84M $2.32M +$4.09M 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017
Q1 2016 -$6.93M -$3.38M -$1.66M -96.6% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$5.27M -$660K -$127K -23.8% 01 Oct 2015 31 Dec 2015 10-K 29 Mar 2017
Q3 2015 -$5.14M -$1.13M -$1.25M -1015% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$3.89M -$1.76M -$1.54M -705% 01 Apr 2015 30 Jun 2015 10-Q 22 Aug 2016
Q1 2015 -$2.35M -$1.72M +$406K +19.1% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$2.75M -$533K -$524K -5858% 01 Oct 2014 31 Dec 2014 10-K 11 Apr 2016
Q3 2014 -$2.23M $123K +$223K 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$2.45M -$219K +$11.4K +4.95% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$2.46M -$2.13M -$1.79M -539% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$671K -$8.95K +$88.9K +90.9% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$760K -$99.8K -$5.31K -5.62% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 -$755K -$230K -$4.49K -1.99% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$750K -$332K +$96.5K +22.5% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$847K -$97.9K +$763K +88.6% 01 Oct 2012 31 Dec 2012 10-K 04 Apr 2014
Q3 2012 -$1.61M -$94.5K +$1.92M +95.3% 01 Jul 2012 30 Sep 2012 10-Q 18 Nov 2013
Q2 2012 -$3.53M -$226K +$1.31M +85.3% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$4.84M -$429K +$1.17M +73.1% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$6.01M -$861K 01 Oct 2011 31 Dec 2011 10-K 16 Apr 2013
Q3 2011 -$2.02M -$430K -27.1% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 -$1.53M -$162K -11.8% 31 Mar 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 -$1.6M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$1.59M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$1.37M 01 Apr 2010 30 Jun 2010 10-Q 05 Aug 2011

REGENERX BIOPHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.73M -$130K -8.12% 01 Jan 2022 31 Dec 2022 10-K 11 Apr 2023
2021 -$1.6M -$74.4K -4.88% 01 Jan 2021 31 Dec 2021 10-K 11 Apr 2023
2020 -$1.52M -$119K -8.48% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 -$1.4M +$589K +29.6% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 -$1.99M -$2.28M -796% 01 Jan 2018 31 Dec 2018 10-K 20 Mar 2020
2017 $286K +$57.4K +25% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $229K +$5.5M 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018
2015 -$5.27M -$2.52M -91.4% 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2017
2014 -$2.75M -$2.08M -310% 01 Jan 2014 31 Dec 2014 10-K 11 Apr 2016
2013 -$671K +$176K +20.7% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$847K +$5.16M +85.9% 01 Jan 2012 31 Dec 2012 10-K 04 Apr 2014
2011 -$6.01M -$983K -19.6% 01 Jan 2011 31 Dec 2011 10-K 16 Apr 2013
2010 -$5.02M 01 Jan 2010 31 Dec 2010 10-K 04 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.